Key takeaways
Trulicity (dulaglutide) and Saxenda (liraglutide) are both GLP-1 agonists, but they are used for different purposes. Trulicity is primarily for managing Type 2 diabetes and reducing the risk of major heart events in adults with heart disease or risk factors. It is injected once a week. To help lower blood sugar. On the other hand, Saxenda is used for weight management in adults and children over 12 with a high BMI, and it is injected daily. While both medications can cause nausea, vomiting, and diarrhea, Saxenda has a higher incidence of these side effects. Trulicity is not approved for weight loss, although some people may experience it as a side effect. Both medications carry risks of thyroid cancer and pancreatitis, and neither should be used by individuals with a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2.
